Abstract

Background

The radionuclide Ga-68 is commonly used in nuclear medicine, specifically in positron emission tomography (PET). Recently, the interest in producing Ga-68 by cyclotron irradiation of [68Zn]Zn nitrate liquid targets is increasing. However, current purification methods of Ga-68 from the target solution consist of multi-step procedures, thus, leading to a significant loss of activity through natural decay. Additionally, several processing steps are needed to recycle the costly, enriched target material.

Results

To eventually allow switching from batch to continuous production, conventional batch extraction and membrane-based microfluidic extraction were compared. In both approaches, Ga-68 was extracted using N-benzoyl-N-phenylhydroxylamine in chloroform as the organic extracting phase. Extraction efficiencies of up to 99.5% ± 0.6% were achieved within 10 min, using the batch approach. Back-extraction of Ga-68 into 2 M HCl was accomplished within 1 min with efficiencies of up to 94.5% ± 0.6%. Membrane-based microfluidic extraction achieved 99.2% ± 0.3% extraction efficiency and 95.8% ± 0.8% back-extraction efficiency into 6 M HCl. When executed on a solution irradiated with a 13 MeV cyclotron at TRIUMF, Canada, comparable efficiencies of 97.0% ± 0.4% were achieved. Zn contamination in the back-extracted Ga-68 solution was found to be below 3 ppm.

Conclusions

Microfluidic solvent extraction is a promising method in the production of Ga-68 achieving high efficiencies in a short amount of time, potentially allowing for direct target recycling.

Details

Title
Membrane-based microfluidic solvent extraction of Ga-68 from aqueous Zn solutions: towards an automated cyclotron production loop
Author
Trapp, Svenja 1   VIAFID ORCID Logo  ; Lammers, Tom 1 ; Engudar, Gokce 2 ; Hoehr, Cornelia 2 ; Denkova, Antonia G. 1 ; Paulssen, Elisabeth 3 ; de Kruijff, Robin M. 1   VIAFID ORCID Logo 

 Delft University of Technology, Department of Radiation Science and Technology, Reactor Institute Delft, Delft, The Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740) 
 TRIUMF, Life Sciences Division, Vancouver, Canada (GRID:grid.232474.4) (ISNI:0000 0001 0705 9791) 
 Delft University of Technology, Department of Radiation Science and Technology, Reactor Institute Delft, Delft, The Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740); Aachen University of Applied Science, Department of Chemistry and Biotechnology, Juelich, Germany (GRID:grid.434081.a) (ISNI:0000 0001 0698 0538) 
Pages
9
Publication year
2023
Publication date
Dec 2023
Publisher
Springer Nature B.V.
e-ISSN
2365-421X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2809982344
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.